Kraig Biocraft Laboratories, Inc.
General ticker "KBLB" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $92.0M (TTM average)
Kraig Biocraft Laboratories, Inc. follows the US Stock Market performance with the rate: 4.2%.
Estimated limits based on current volatility of 2.9%: low 0.08$, high 0.09$
Factors to consider:
- Total employees count: 2 as of 2014
- Top business risk factors: Economic downturns and volatility, Insufficient cash flow, Need for additional capital, Limited operating history, Limited resources
- Current price 50.6% above estimated high
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [0.02$, 0.05$]
- 2024-12-30 to 2025-12-30 estimated range: [0.02$, 0.06$]
Financial Metrics affecting the KBLB estimates:
- Positive: with PPE of -14.0 at the end of fiscal year the price was very low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.94 <= 0.33
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.02 > -0.66
- Positive: Inventory ratio change, % of 0 <= 0.84
- Negative: Shareholder equity ratio, % of -176.53 <= 18.93
Short-term KBLB quotes
Long-term KBLB plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.76MM | $2.12MM | $2.61MM |
| Operating Income | $-2.76MM | $-2.12MM | $-2.61MM |
| Non-Operating Income | $-5.29MM | $-1.72MM | $-0.41MM |
| Interest Expense | $0.66MM | $0.61MM | $0.48MM |
| R&D Expense | $0.20MM | $0.18MM | $0.24MM |
| Income(Loss) | $-8.05MM | $-3.84MM | $-3.03MM |
| Profit(Loss)* | $-8.05MM | $-3.84MM | $-3.03MM |
| Stockholders Equity | $-5.30MM | $-3.52MM | $-5.71MM |
| Inventory | $0.00MM | $0.01MM | $0.01MM |
| Assets | $3.02MM | $4.57MM | $3.23MM |
| Operating Cash Flow | $-1.80MM | $-1.89MM | $-1.24MM |
| Capital expenditure | $0.10MM | $0.01MM | $0.01MM |
| Investing Cash Flow | $-0.55MM | $-0.01MM | $-0.01MM |
| Financing Cash Flow | $3.89MM | $3.40MM | $-0.06MM |
| Earnings Per Share** | $-0.01 | $-0.00 | $-0.00 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.